These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26126631)

  • 1. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics.
    Swomley AM; Butterfield DA
    Arch Toxicol; 2015 Oct; 89(10):1669-80. PubMed ID: 26126631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
    Sultana R; Perluigi M; Butterfield DA
    Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.
    Butterfield DA; Boyd-Kimball D
    J Neurochem; 2019 Nov; 151(4):459-487. PubMed ID: 30216447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
    Butterfield DA
    Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
    Butterfield DA; Reed T; Newman SF; Sultana R
    Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.
    Butterfield DA; Sultana R
    J Alzheimers Dis; 2007 Aug; 12(1):61-72. PubMed ID: 17851195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress, protein modification and Alzheimer disease.
    Tramutola A; Lanzillotta C; Perluigi M; Butterfield DA
    Brain Res Bull; 2017 Jul; 133():88-96. PubMed ID: 27316747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.
    Sultana R; Butterfield DA
    J Bioenerg Biomembr; 2009 Oct; 41(5):441-6. PubMed ID: 19777328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
    Butterfield DA; Boyd-Kimball D
    J Alzheimers Dis; 2018; 62(3):1345-1367. PubMed ID: 29562527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.
    Swomley AM; Förster S; Keeney JT; Triplett J; Zhang Z; Sultana R; Butterfield DA
    Biochim Biophys Acta; 2014 Aug; 1842(8):1248-57. PubMed ID: 24120836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
    Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
    Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoproteomics of Alzheimer disease brain: Insights into altered brain protein regulation of critical neuronal functions and their contributions to subsequent cognitive loss.
    Butterfield DA
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2031-2039. PubMed ID: 31167728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: redox proteomics study.
    Sultana R; Newman SF; Abdul HM; Cai J; Pierce WM; Klein JB; Merchant M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):409-17. PubMed ID: 16634065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.
    Butterfield DA; Swomley AM; Sultana R
    Antioxid Redox Signal; 2013 Sep; 19(8):823-35. PubMed ID: 23249141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease.
    Butterfield DA; Boyd-Kimball D
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32887505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
    Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA
    J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.